428 related articles for article (PubMed ID: 6424239)
1. Rocky Mountain spotted fever vaccine: a regional need.
Walker DH; Montenegro MR; Hegarty BC; Tringali GR
South Med J; 1984 Apr; 77(4):447-9. PubMed ID: 6424239
[TBL] [Abstract][Full Text] [Related]
2. "Rickettsia amblyommii" induces cross protection against lethal Rocky Mountain spotted fever in a guinea pig model.
Blanton LS; Mendell NL; Walker DH; Bouyer DH
Vector Borne Zoonotic Dis; 2014 Aug; 14(8):557-62. PubMed ID: 25072985
[TBL] [Abstract][Full Text] [Related]
3. A recombinant Rickettsia conorii vaccine protects guinea pigs from experimental boutonneuse fever and Rocky Mountain spotted fever.
Vishwanath S; McDonald GA; Watkins NG
Infect Immun; 1990 Mar; 58(3):646-53. PubMed ID: 2106490
[TBL] [Abstract][Full Text] [Related]
4. Rocky Mountain spotted fever vaccine in an animal model.
Folds JD; Walker DH; Hegarty BC; Banasiak D; Lange JV
J Clin Microbiol; 1983 Aug; 18(2):321-6. PubMed ID: 6413529
[TBL] [Abstract][Full Text] [Related]
5. Rickettsia rickettsii Whole-Cell Antigens Offer Protection against Rocky Mountain Spotted Fever in the Canine Host.
Alhassan A; Liu H; McGill J; Cerezo A; Jakkula LUMR; Nair ADS; Winkley E; Olson S; Marlow D; Sahni A; Narra HP; Sahni S; Henningson J; Ganta RR
Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30396898
[TBL] [Abstract][Full Text] [Related]
6. New assay of protective activity of Rocky Mountain spotted fever vaccines.
Anacker RL; Smith RF; Mann RE; Hamilton MA
J Clin Microbiol; 1976 Sep; 4(3):309-11. PubMed ID: 823177
[TBL] [Abstract][Full Text] [Related]
7. Extraction of protective components of Rickettsia rickettsii with n-octyl-beta-D-glucopyranoside.
McDonald GA; Anacker RL; Mann RE
Rev Infect Dis; 1988; 10 Suppl 2():S382-5. PubMed ID: 3142019
[TBL] [Abstract][Full Text] [Related]
8. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization.
Kenyon RH; Pedersen CE
J Clin Microbiol; 1975 Jun; 1(6):500-3. PubMed ID: 809483
[TBL] [Abstract][Full Text] [Related]
9. Failure of a heterologous recombinant Sca5/OmpB protein-based vaccine to elicit effective protective immunity against Rickettsia rickettsii infections in C3H/HeN mice.
Riley SP; Cardwell MM; Chan YG; Pruneau L; Del Piero F; Martinez JJ
Pathog Dis; 2015 Dec; 73(9):ftv101. PubMed ID: 26519448
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three rocky mountain spotted fever vaccines.
Kenyon RH; Sammons LS; Pedersen CE
J Clin Microbiol; 1975 Oct; 2(4):300-4. PubMed ID: 810494
[TBL] [Abstract][Full Text] [Related]
11. Laboratory-acquired Rocky Mountain spotted fever. The hazard of aerosol transmission.
Oster CN; Burke DS; Kenyon RH; Ascher MS; Harber P; Pedersen CE
N Engl J Med; 1977 Oct; 297(16):859-63. PubMed ID: 409947
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a killed Rocky Mountain spotted fever vaccine in cynomolgus monkeys.
Gonder JC; Kenyon RH; Pedersen CE
J Clin Microbiol; 1979 Nov; 10(5):719-23. PubMed ID: 120877
[TBL] [Abstract][Full Text] [Related]
13. Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever.
Clements ML; Wisseman CL; Woodward TE; Fiset P; Dumler JS; McNamee W; Black RE; Rooney J; Hughes TP; Levine MM
J Infect Dis; 1983 Nov; 148(5):922-30. PubMed ID: 6415182
[TBL] [Abstract][Full Text] [Related]
14. Surface protein Adr2 of Rickettsia rickettsii induced protective immunity against Rocky Mountain spotted fever in C3H/HeN mice.
Gong W; Xiong X; Qi Y; Jiao J; Duan C; Wen B
Vaccine; 2014 Apr; 32(18):2027-33. PubMed ID: 24582636
[TBL] [Abstract][Full Text] [Related]
15. Cross-protection between distantly related spotted fever group rickettsiae.
Feng HM; Walker DH
Vaccine; 2003 Sep; 21(25-26):3901-5. PubMed ID: 12922124
[TBL] [Abstract][Full Text] [Related]
16. Protection of guinea pigs from experimental Rocky Mountain spotted fever with a cloned antigen of Rickettsia rickettsii.
McDonald GA; Anacker RL; Mann RE; Milch LJ
J Infect Dis; 1988 Jul; 158(1):228-31. PubMed ID: 3134494
[No Abstract] [Full Text] [Related]
17. Cell-mediated immune responses of adults to vaccination, challenge with Rickettsia rickettsii, or both.
Dumler JS; Wisseman CL; Fiset P; Clements ML
Am J Trop Med Hyg; 1992 Feb; 46(2):105-15. PubMed ID: 1539743
[TBL] [Abstract][Full Text] [Related]
18. Spotted fever vaccine; potency assay by direct challenge of vaccinated mice with toxin of Rickettsia rickettsii.
BELL EJ; STOENNER HG
J Immunol; 1961 Dec; 87():737-46. PubMed ID: 13866804
[No Abstract] [Full Text] [Related]
19. In vitro guinea pig leukocyte reactions to Rickettsia rickettsii.
Kenyon RH; Ascher MS; Kishimoto RA; Pedersen CE
Infect Immun; 1977 Dec; 18(3):840-6. PubMed ID: 412792
[TBL] [Abstract][Full Text] [Related]
20. Rocky Mountain spotted fever: a comparative study of the active immunity induced by inactivated and viable pathogenic Rickettsia rickettsii.
DuPont HL; Hornick RB; Dawkins AT; Heiner GG; Fabrikant IB; Wisseman CL; Woodward TE
J Infect Dis; 1973 Sep; 128(3):340-4. PubMed ID: 4199563
[No Abstract] [Full Text] [Related]
[Next] [New Search]
